Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 19Breast Neoplasms 13Brain Neoplasms 11Agnosia 7Neoplasms 6Lung Neoplasms 5Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Pituitary Neoplasms 3Pain 3Inflammation 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Abdominal Neoplasms 2Thrombosis 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1

Interventions

Fentanyl 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abdominal Cancer Surgeries × Dexmedetomidine × Clear all
NCT07214714 2025-10-09

Hemodynamic and Cardiac Effects of Dexmedetomidine Versus Fentanyl by Intravenous Infusion as Adjuncts to General Anesthesia in Patients Undergoing Major Abdominal Cancer Surgeries.

Assiut University

Phase 4 Not yet recruiting
70 enrolled

Abdominal Cancer Surgeries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡